1. To provide a brief history on the treatment of head and neck squamous cell carcinoma
  2. To discuss methods to improve induction therapy response rate in head and neck cancer
  3. To describe the role of combination immunotherapy and radiation in non-small cell lung cancer


Session date: 
08/27/2018 - 12:00pm to 1:00pm CDT
5841 South Maryland Avenue
MC2115 HemOnc Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Michael J. Jelinek, MD